Growing B2B Capacity The company is investing heavily to expand production capacity, warehousing, and laboratories, signaling readiness for larger distribution partnerships and increased contract manufacturing opportunities.

Biosimilar Expansion With a dedicated biotechnology unit established in 2024, there is a clear trajectory to scale biosimilar products, opening potential for collaboration in biologics development, manufacturing, and licensing deals.

Female Health Focus Strong presence in gynecology in Germany since 2011 positions the company as a preferred partner for women’s health therapies, suggesting opportunities in specialty channels, hospital partnerships, and payer-oriented programs.

Global Access As a global innovator targeting broader access to high-quality medicines, there is potential to partner on distributed supply, market access strategies, and regional expansion initiatives in emerging markets.

Digital & Data Readiness Adoption of digital tools and platforms across ERP, CRM, and analytics indicates readiness for integrated sales enablement, e-commerce collaborations, and data-driven market intelligence partnerships.